Johnson & Johnson
JNJ
#19
Rank
NZ$999.17 B
Marketcap
NZ$414.61
Share price
0.78%
Change (1 day)
52.10%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

Operating Margin for Johnson & Johnson (JNJ)

Operating Margin at the end of 2025: 34.59%

According to Johnson & Johnson's latest financial reports and stock price the company's current Operating Margin is 34.58%. At the end of 2025 the company had an Operating Margin of 34.59%.

Operating Margin history for Johnson & Johnson from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202534.59%84.11%
202418.79%6.22%
202317.69%-26.92%
202224.20%-0.63%
202124.36%21.93%
202019.98%-5.4%
201921.12%-4.29%
201822.06%-4.56%
201723.12%-16.08%
201627.55%0.56%
201527.39%-0.98%
201427.66%27.51%
201321.69%5.87%
201220.49%7.8%
201119.01%-30.92%
201027.52%8.11%
200925.45%-4.15%
200826.56%22.15%
200721.74%-20.52%
200627.36%5.35%
200525.97%-0.3%
200426.04%5.77%
200324.62%-3.8%
200225.60%4.74%
200124.44%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Novartis
NVS
28.85%-16.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
12.60%-63.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
18.56%-46.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.78%-51.47%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
39.47% 14.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
15.12%-56.28%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
33.98%-1.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
20.38%-41.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-10.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
22.01%-36.35%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.